Ampio's years of troubles come to a head with internal investigation, trio of COVID trial failures

An osteoarthritis trial ravaged by COVID, an FDA rejection, three failed clinical trials in COVID and now this: Ampio’s board is conducting an internal investigation and considering a sale.